3-[(R)-[4-(1,3-benzothiazol-2-yl)piperazin-1-yl]-(1-cyclohexyltetrazol-5-yl)methyl]-6-methyl-1H-quinolin-2-one

C29H32N8OS — CID 1156848

IUPAC3-[(R)-[4-(1,3-benzothiazol-2-yl)piperazin-1-yl]-(1-cyclohexyltetrazol-5-yl)methyl]-6-methyl-1H-quinolin-2-one
SMILESCc1ccc2[nH]c(=O)c([C@H](c3nnnn3C3CCCCC3)N3CCN(c4nc5ccccc5s4)CC3)cc2c1
InChIInChI=1S/C29H32N8OS/c1-19-11-12-23-20(17-19)18-22(28(38)30-23)26(27-32-33-34-37(27)21-7-3-2-4-8-21)35-13-15-36(16-14-35)29-31-24-9-5-6-10-25(24)39-29/h5-6,9-12,17-18,21,26H,2-4,7-8,13-16H2,1H3,(H,30,38)/t26-/m1/s1
InChIKeyNGKXDKONLLUHBK-AREMUKBSSA-N
MW540.70 g/mol
LogP4.85
Rot. Bonds5

About 3-[(R)-[4-(1,3-benzothiazol-2-yl)piperazin-1-yl]-(1-cyclohexyltetrazol-5-yl)methyl]-6-methyl-1H-quinolin-2-one

3-[(R)-[4-(1,3-benzothiazol-2-yl)piperazin-1-yl]-(1-cyclohexyltetrazol-5-yl)methyl]-6-methyl-1H-quinolin-2-one (PubChem CID 1156848) has the molecular formula C29H32N8OS and a molecular weight of 540.70 g/mol. Its IUPAC name is 3-[(R)-[4-(1,3-benzothiazol-2-yl)piperazin-1-yl]-(1-cyclohexyltetrazol-5-yl)methyl]-6-methyl-1H-quinolin-2-one.

Molecular Properties

Compound Name3-[(R)-[4-(1,3-benzothiazol-2-yl)piperazin-1-yl]-(1-cyclohexyltetrazol-5-yl)methyl]-6-methyl-1H-quinolin-2-one
PubChem CID1156848
Molecular FormulaC29H32N8OS
Molecular Weight540.70 g/mol
Exact Mass540.24
IUPAC Name3-[(R)-[4-(1,3-benzothiazol-2-yl)piperazin-1-yl]-(1-cyclohexyltetrazol-5-yl)methyl]-6-methyl-1H-quinolin-2-one
SMILESCc1ccc2[nH]c(=O)c([C@H](c3nnnn3C3CCCCC3)N3CCN(c4nc5ccccc5s4)CC3)cc2c1
InChIInChI=1S/C29H32N8OS/c1-19-11-12-23-20(17-19)18-22(28(38)30-23)26(27-32-33-34-37(27)21-7-3-2-4-8-21)35-13-15-36(16-14-35)29-31-24-9-5-6-10-25(24)39-29/h5-6,9-12,17-18,21,26H,2-4,7-8,13-16H2,1H3,(H,30,38)/t26-/m1/s1
InChIKeyNGKXDKONLLUHBK-AREMUKBSSA-N
XLogP4.85
TPSA95.83 Ų
H-Bond Donors1
H-Bond Acceptors9
Rotatable Bonds5
Heavy Atoms39
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500540.70
LogP ≤ 54.85
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 109

Analyze 3-[(R)-[4-(1,3-benzothiazol-2-yl)piperazin-1-yl]-(1-cyclohexyltetrazol-5-yl)methyl]-6-methyl-1H-quinolin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-[(R)-[4-(1,3-benzothiazol-2-yl)piperazin-1-yl]-(1-cyclohexyltetrazol-5-yl)methyl]-6-methyl-1H-quinolin-2-one?
The IUPAC name of 3-[(R)-[4-(1,3-benzothiazol-2-yl)piperazin-1-yl]-(1-cyclohexyltetrazol-5-yl)methyl]-6-methyl-1H-quinolin-2-one (CID 1156848) is 3-[(R)-[4-(1,3-benzothiazol-2-yl)piperazin-1-yl]-(1-cyclohexyltetrazol-5-yl)methyl]-6-methyl-1H-quinolin-2-one.
What is the SMILES notation for 3-[(R)-[4-(1,3-benzothiazol-2-yl)piperazin-1-yl]-(1-cyclohexyltetrazol-5-yl)methyl]-6-methyl-1H-quinolin-2-one?
The canonical SMILES for 3-[(R)-[4-(1,3-benzothiazol-2-yl)piperazin-1-yl]-(1-cyclohexyltetrazol-5-yl)methyl]-6-methyl-1H-quinolin-2-one is Cc1ccc2[nH]c(=O)c([C@H](c3nnnn3C3CCCCC3)N3CCN(c4nc5ccccc5s4)CC3)cc2c1.
What is the InChIKey of 3-[(R)-[4-(1,3-benzothiazol-2-yl)piperazin-1-yl]-(1-cyclohexyltetrazol-5-yl)methyl]-6-methyl-1H-quinolin-2-one?
The InChIKey is NGKXDKONLLUHBK-AREMUKBSSA-N. The full InChI is InChI=1S/C29H32N8OS/c1-19-11-12-23-20(17-19)18-22(28(38)30-23)26(27-32-33-34-37(27)21-7-3-2-4-8-21)35-13-15-36(16-14-35)29-31-24-9-5-6-10-25(24)39-29/h5-6,9-12,17-18,21,26H,2-4,7-8,13-16H2,1H3,(H,30,38)/t26-/m1/s1.
What are the key properties of 3-[(R)-[4-(1,3-benzothiazol-2-yl)piperazin-1-yl]-(1-cyclohexyltetrazol-5-yl)methyl]-6-methyl-1H-quinolin-2-one?
3-[(R)-[4-(1,3-benzothiazol-2-yl)piperazin-1-yl]-(1-cyclohexyltetrazol-5-yl)methyl]-6-methyl-1H-quinolin-2-one has a molecular weight of 540.70 g/mol, XLogP of 4.85, 5 rotatable bonds, 1 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[(R)-[4-(1,3-benzothiazol-2-yl)piperazin-1-yl]-(1-cyclohexyltetrazol-5-yl)methyl]-6-methyl-1H-quinolin-2-one is sourced from PubChem (CID 1156848), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).